Prime Success

Prime Success L.P., holding an 8% stake in Sinovac Biotech, issued a statement criticizing the company’s upcoming shareholder meeting on July 8, 2025, and the actions of the current board (“1Globe Activist Board”). Prime Success, a large shareholder, accuses the board of misleading statements regarding dividend distribution timing and manipulating facts. They advocate for a dividend payout before the meeting and urge shareholders to vote for a new board nominated by SAIF, emphasizing the critical need for competent leadership focused on the company’s long-term success.